Type 2 & other diabetes

Joint longitudinal and time‐to‐event modelling compared with standard Cox modelling in patients with type 2 diabetes with and without established cardiovascular disease: An analysis of the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) trial

Diabetes Obes MetabPublished Secondary analysis of the EXSCEL randomised trial

Authors' conclusion

The analysis demonstrates that the joint modelling approach, considering trajectories of cardiovascular risk factors, provides superior predictive performance compared to standard RPTs that use only a single timepoint.

Study context

Population
Patients with T2D with and without established cardiovascular disease (CVD) in the EXSCEL trial
Comparison
Bayesian joint model vs Cox proportional hazards model
Primary endpoint
Predictive performance for major adverse cardiovascular events (MACE): time-dependent AUC of ROC (aROC) for discrimination and time-dependent Brier score for calibration
Methodological detailsprediction modelling, Bayesian joint model vs Cox proportional hazards model
  • Prediction modelling
  • Bayesian joint model vs Cox proportional hazards model

Primary result

As reported in the abstract

aROC for MACE prediction, participants without history of CVD

aROC of systolic blood pressure (SBP), single vs repeated measurements

0.62 to 0.69

aROC of SBP and low-density lipoprotein cholesterol (LDL-C), single vs repeated measurements

0.67 to 0.80

Further findings

Improvement evident with and without history of CVD, more pronounced in those without

Original publication

Joint longitudinal and time‐to‐event modelling compared with standard Cox modelling in patients with type 2 diabetes with and without established cardiovascular disease: An analysis of the EXSCEL trial. Diabetes Obes Metab. Published 1 February 2023. doi:10.1111/dom.14975

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.